These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30637602)

  • 1. Gay and Bisexual Men's Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study.
    Grov C; Flynn AWP; D'Angelo AB; Lopez-Rios J; Pantalone DW; Holloway IW; Parsons JT
    Prev Sci; 2019 Jan; 20(1):168-177. PubMed ID: 30637602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Do Gay and Bisexual Men Make Up for Missed PrEP Doses, and What Impact Does Missing a Dose Have on Their Subsequent Sexual Behavior?
    Grov C; D'Angelo AB; Flynn AWP; Lopez-Rios J; Pantalone DW; Holloway IW; Whitfield THF; Parsons JT
    AIDS Educ Prev; 2018 Aug; 30(4):275-286. PubMed ID: 30148670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: A qualitative study.
    Maxwell S; Shahmanesh M; Gafos M
    Int J Drug Policy; 2022 May; 103():103630. PubMed ID: 35231668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
    John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
    AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to use and have sex with men taking HIV pre-exposure prophylaxis (PrEP): results of online surveys of Australian gay and bisexual men, 2011-2015.
    Holt M; Lea T; Schmidt HM; Kolstee J; Ellard J; Murphy D; Truong HH; de Wit J
    Sex Transm Infect; 2017 Sep; 93(6):438-444. PubMed ID: 28108701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.
    Whitfield THF; John SA; Rendina HJ; Grov C; Parsons JT
    AIDS Behav; 2018 Nov; 22(11):3566-3575. PubMed ID: 29404756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project.
    Vaccher SJ; Marzinke MA; Templeton DJ; Haire BG; Ryder N; McNulty A; Foster R; Grulich AE; Zablotska IB; ;
    AIDS Behav; 2019 May; 23(5):1287-1296. PubMed ID: 30523489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM).
    Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B
    AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study.
    Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R;
    Lancet HIV; 2021 Aug; 8(8):e486-e494. PubMed ID: 34217426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual goals and perceptions of goal congruence in individuals' PrEP adoption decisions: A mixed-methods study of gay and bisexual men who are in primary relationships.
    Gamarel KE; Golub SA
    Ann Behav Med; 2020 Mar; 54(4):237-248. PubMed ID: 31624825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of Awareness of and Willingness to Use Pre-exposure Prophylaxis (PrEP) in Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Geosocial-Networking Smartphone Applications in New York City.
    Goedel WC; Halkitis PN; Greene RE; Duncan DT
    AIDS Behav; 2016 Jul; 20(7):1435-42. PubMed ID: 26966013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study.
    Closson EF; Mitty JA; Malone J; Mayer KH; Mimiaga MJ
    AIDS Care; 2018 Feb; 30(2):191-198. PubMed ID: 28830220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Patterns of Discontinuing and Recommencing Pre-exposure Prophylaxis in the Context of Sexual Behavior Among Gay and Bisexual Men in Australia.
    Philpot SP; Murphy D; Chan C; Haire B; Wells N; Fraser D; Grulich AE; Bavinton BR
    AIDS Behav; 2023 Sep; 27(9):2891-2901. PubMed ID: 36811738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.
    Grace D; Jollimore J; MacPherson P; Strang MJP; Tan DHS
    AIDS Patient Care STDS; 2018 Jan; 32(1):24-30. PubMed ID: 29185801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should I Convince My Partner to Go on Pre-Exposure Prophylaxis (PrEP)? The Role of Personal and Relationship Factors on PrEP-Related Social Control among Gay and Bisexual Men.
    John SA; Starks TJ; Rendina HJ; Grov C; Parsons JT
    AIDS Behav; 2018 Apr; 22(4):1239-1252. PubMed ID: 28634660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the Roles that Club Drugs, Marijuana, and Heavy Drinking Play in PrEP Medication Adherence Among Gay and Bisexual Men: Implications for Treatment and Research.
    Grov C; Rendina HJ; John SA; Parsons JT
    AIDS Behav; 2019 May; 23(5):1277-1286. PubMed ID: 30306433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
    Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE;
    BMC Public Health; 2018 Feb; 18(1):210. PubMed ID: 29394918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of HIV Pre-exposure Prophylaxis (PrEP) Associated With Lower HIV Anxiety Among Gay and Bisexual Men in Australia Who Are at High Risk of HIV Infection: Results From the Flux Study.
    Keen P; Hammoud MA; Bourne A; Bavinton BR; Holt M; Vaccher S; Haire B; Saxton P; Jin F; Maher L; Grulich AE; Prestage G
    J Acquir Immune Defic Syndr; 2020 Feb; 83(2):119-125. PubMed ID: 31935203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.
    Parsons JT; Rendina HJ; Whitfield TH; Grov C
    AIDS Behav; 2016 Jul; 20(7):1390-9. PubMed ID: 27000145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.